Jackson Thornton Wealth Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$320K Sell
1,222
-652
-35% -$167K 0.02% 232
2026
Q2
$472K Buy
+1,874
New +$403K 0.04% 164
2026
Q1
– Sell
-1,776
Closed -$398K – 287
2025
Q4
$398K Buy
1,776
+297
+20% +$67.7K 0.04% 143
2025
Q3
$342K Buy
1,479
+24
+2% +$4.89K 0.03% 159
2025
Q2
$276K Buy
1,455
+82
+6% +$15.2K 0.03% 92
2025
Q1
$238K Buy
1,373
+173
+14% +$33.6K 0.03% 80
2024
Q4
$213K Buy
1,200
+2
+0.2% +$368 0.03% 78
2024
Q3
$237K Sell
1,198
-4
-0.3% -$747 0.03% 56
2024
Q2
$206K Sell
1,202
-29
-2% -$4.8K 0.03% 53
2024
Q1
$224K Buy
+1,231
New +$212K 0.04% 48
2022
Q3
– Sell
-1,446
Closed -$221K – 30
2022
Q2
$221K Buy
1,446
+192
+15% +$29.3K 0.06% 24
2022
Q1
$203K Buy
+1,254
New +$182K 0.05% 25

Other funds holding ABBV

Jackson Thornton Wealth Management's ABBV Position: Q3 2026 in Review

Jackson Thornton Wealth Management reduced its AbbVie (ABBV) stake by 35% in Q3 2026, selling an estimated $167K and leaving 1,222 shares worth $320K. The position accounts for 0.02% of the portfolio, ranked #232.

Jackson Thornton Wealth Management first reported a position in ABBV in Q1 2022 and has held it in 12 quarters since. The position peaked at $472K in Q2 2026. 4,279 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Jackson Thornton Wealth Management held 1,222 shares of AbbVie worth $320K as of Q3 2026.
  • Jackson Thornton Wealth Management sold 652 AbbVie shares in Q3 2026, an estimated $167K.
  • AbbVie made up 0.02% of Jackson Thornton Wealth Management's portfolio in Q3 2026, its #232 holding.
  • Jackson Thornton Wealth Management first reported a position in AbbVie in Q1 2022 and has held it in 12 quarters since.
  • Jackson Thornton Wealth Management's AbbVie position peaked at $472K in Q2 2026.
  • 4,279 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Jackson Thornton Wealth Management's 13F filing for Q3 2026, filed 12 Nov 2026.